Literature DB >> 8255498

[The role of the Vabra aspirator in the screening of endometrial carcinoma. Our experience].

M Leonardi1, P Provenzale, L Zanardini, G Bellicini.   

Abstract

The aim of study was to estimate the utility of Vabra aspirator in the screening of endometrial carcinoma. For this and 656 patients aged over 40 were subjected to cytologic examination and we compared the date obtained with the histologic examination, when the woman was subjected to surgical operation. The research which we carried out was of the retrospective type and it lasted two years. The patients were recruited at the division out-clinic and locally. All the examinations were carried out at the division, using the method of Vabra aspirator with the Kit of Sterilab. The patients admitted to examination showed some menstrual anomalies, (spotting, abnormal uterine bleeding, metrorrhagias and after postmenopausal uterine bleeding), and stayed at our USSL or at neighbouring ones. The cytologic examination have been read beside a single centre and the cytologic diagnosis has been compared with the histology one on the operating organ. The result obtained agrees with the literature. In fact, out of 888 screened women, 656 were aged over 40 and 232 aged less than 40. In the group of 656 patients 3 adenocarcinoma have been diagnosed and 4 atypical hyperplasia, equivalent to 0.33% and to 0.45% respectively. In conclusion, we can say that the method has shown a good diagnostic reliability into the diagnosis of malignant neoplasia. According to other authors, its limit is, instead, the high number of inadequate, besides the impossibility to diagnose other uterine pathologies, such as the endometrial polyps and the uterine myoma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8255498

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  1 in total

Review 1.  Endometrial sampling devices for early diagnosis of endometrial lesions.

Authors:  Jiang Du; Yaling Li; Shulan Lv; Qing Wang; Chao Sun; Xin Dong; Ming He; Qurat Ulain; Yongxing Yuan; Xiaoqian Tuo; Nasra Batchu; Qing Song; Qiling Li
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-11       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.